Purchase Order SPE2DP25P0431
- Not listed
- The U.S. Department of Defense's Medical Supply Chain has awarded a firm fixed-price purchase order totaling $2,010.06 to The Maclean Group LLC for the supply of naloxone hydrochloride. The award, issued on August 13, 2025, with an ultimate completion date of August 28, 2025, represents a small-value procurement with no set-aside designation. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, is an ISO 9001:2015 certified medical and...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medical supply. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that holds several federal contract...
- The U.S. Medical Supply Chain (Defense) awarded a firm fixed-price purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, for the supply of Naloxone Hydrochloride. The contract, valued at $1,005.03, was awarded on September 5, 2025, with an ultimate completion date of September 22, 2025. No set-aside designation was applied to this procurement. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
- The U.S. Department of Defense's Medical Supply Chain awarded a purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, for the procurement of Naloxone Hydrochloride. The contract, awarded on April 24, 2025, carries a ceiling value of $6,030.18 and is structured as a firm fixed-price purchase order with an ultimate completion date of May 9, 2025. The award utilizes no set-aside designation and will be performed in...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,010.06 firm fixed-price purchase order to The Maclean Group LLC for naloxone hydrochloride, with an ultimate completion date of September 24, 2025. This contract, issued on September 9, 2025, carries no set-aside designation and specifies performance at The Maclean Group's Sacramento, California location. The Maclean Group is a service-disabled veteran-owned small business (SDVOSB) and ISO 9001:2015 certified pharmaceutical and...
- The U.S. Department of Defense's Medical Supply Chain agency awarded a $1,005.03 firm fixed price purchase order to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The award is for the delivery of naloxone hydrochloride, a medication used to reverse opioid overdose, and has a period of performance through March 13, 2025. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical...
- The Medical Supply Chain, a defense-focused federal agency, awarded a purchase order to The Maclean Group LLC for naloxone hydrochloride on September 19, 2025, with a ceiling value of $2,010.06 and an ultimate completion date of October 6, 2025. This firm fixed-price contract with no set-aside designation procures a critical opioid antagonist medication essential for emergency response and overdose reversal. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) based in...
- The U.S. Department of Defense Medical Supply Chain awarded a firm fixed-price purchase order to The Maclean Group LLC on July 22, 2025, for the delivery of Naloxone Hydrochloride with a ceiling value of $7,035.21. The contract is scheduled for completion by August 6, 2025, and performance will take place in Sacramento, California. This award was issued without a set-aside designation. The Maclean Group, a service-disabled veteran-owned small business (SDVOSB) and ISO 9001:2015 certified...
- The U.S. government agency Medical Supply Chain has awarded a $1,005.03 firm fixed-price purchase order contract to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The contract is for the delivery of naloxone hydrochloride, a critical medical product used to treat opioid overdoses. This contract is not set aside for any specific business category. The Maclean Group is an ISO 9001:2015...
- This is a federal purchase order awarded by the Medical Supply Chain of the Defense Department to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business based in Sacramento, California. The $1,005.03 firm fixed-price contract is for the delivery of naloxone hydrochloride, with a performance period ending on April 24, 2025. The Maclean Group is an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor that has...
The U.S. Department of Defense's Medical Supply Chain awarded a $13,065.39 firm fixed-price purchase order to The Maclean Group LLC, a service-disabled veteran-owned small business (SDVOSB) based in Sacramento, California, for naloxone hydrochloride. The award, issued on May 30, 2025, with an ultimate completion date of June 16, 2025, represents a direct procurement with no set-aside designation applied. The Maclean Group, an ISO 9001:2015 certified medical and pharmaceutical wholesale distributor, specializes in medical equipment distribution and pharmaceutical supply to federal agencies and leverages its veteran-owned status to support government procurement objectives. As an established federal contractor with multiple indefinite delivery vehicles including a $2.63 million Federal Supply Schedule contract with the Department of Veterans Affairs for medical equipment and supplies and a $500,000 GSA Federal Supply Schedule contract for HVAC systems and water treatment technologies, The Maclean Group has demonstrated capability in delivering critical medical supplies across the Department of Defense and other federal agencies. The naloxone hydrochloride procurement supports the Medical Supply Chain's operational requirements for this opioid antagonist medication, which is essential for emergency response and overdose treatment protocols within military and defense medical facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 5/30/25 |